Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$51.9M
+38.7% from 2023
Prescriptions
2,144
$24,210.87 per claim
Patients
627
607 prescribers
Total spending, 2024
$52.0M
$82,777.54 per patient
Medicare prescription drug plans paid $51.9M for Livtencity in 2024, for 2,144 prescriptions and refills to 627 patients (up 38.7% from 2023). The average cost per claim was $24,210.87.
New York had the highest Medicare cost for Livtencity in 2024: $9.1M for 376 claims, followed by Texas ($3.8M).
Shehzad Ali, nephrology in Syracuse, NY, had the highest Medicare cost for Livtencity in 2024: 46 claims costing $1.1M.
Livtencity is made by Takeda Pharmaceutical Company Limited (TAK), listed in the Medicare spending data as Takeda Pharmace.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Shehzad Ali Syracuse, NY | Nephrology | 46 | Under 11 | $1.1M |
| Jamie N Hum New York, NY | Nurse Practitioner | 27 | Under 11 | $668K |
| Alexandra Mills Charleston, SC |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 258 | 791 | 244 | $20.2M |
| 2023 | 424 | 1,457 | 432 | $37.4M |
| 2024 | 607 | 2,144 | 627 | $51.9M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Infectious Disease |
| 24 |
| Under 11 |
| $575K |
| Vaqar Ahmed Teaneck, NJ | Nephrology | 24 | Under 11 | $571K |
| Naseeruddin A Khan Baton Rouge, LA | Nephrology | 23 | Under 11 | $570K |
| Pradeep Kumar Vaitla Jackson, MS | Nephrology | 22 | Under 11 | $524K |
| Diane G Cascioli Carmel, NY | Nurse Practitioner | 21 | Under 11 | $519K |
| Himabindu Yerneni Cleveland, OH | Nephrology | 19 | Under 11 | $476K |
| Thomas J Dimaria Danville, PA | Nurse Practitioner | 19 | Under 11 | $468K |
| Kavya B Patel Cincinnati, OH | Infectious Disease | 18 | Under 11 | $459K |
| Lorenzo Zaffiri Atlanta, GA | Pulmonary Disease | 18 | Under 11 | $456K |
| Yevgeniy Brailovsky New York, NY | Cardiology | 18 | Under 11 | $435K |
| Imran Y Gani Augusta, GA | Nephrology | 17 | Under 11 | $418K |
| Sapna Shah Los Angeles, CA | Nephrology | 16 | Under 11 | $405K |
| Kathryn A Ripley Norfolk, VA | Nurse Practitioner | 15 | Under 11 | $381K |
| Angelito F Yango Fort Worth, TX | Nephrology | 13 | Under 11 | $330K |
| Koshy O Abraham Fort Worth, TX | Nephrology | 13 | Under 11 | $320K |
| Mitchell C Li New York, NY | Nurse Practitioner | 14 | Under 11 | $318K |
| Vinita Sehgal New York, NY | Nephrology | 12 | Under 11 | $306K |
| Yasir A Qazi Orange, CA | Nephrology | 12 | Under 11 | $304K |
| John R Lee New York, NY | Nephrology | 12 | Under 11 | $304K |
| Imad Omer Memphis, TN | Infectious Disease | 12 | Under 11 | $304K |
| Mark A Kleman Chapel Hill, NC | Nephrology | 13 | Under 11 | $299K |
| Marianna B Gisoldi St Petersburg, FL | Nurse Practitioner | 13 | Under 11 | $292K |
| Peter A Burke Jr. Newark, DE | Internal Medicine | 11 | Under 11 | $279K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Takeda Pharmace TAK | 2,147 | $52.0M |